4.8 Article

Molecular basis for fibroblast growth factor 23 O-glycosylation by GalNAc-T3

Journal

NATURE CHEMICAL BIOLOGY
Volume 16, Issue 3, Pages 351-+

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41589-019-0444-x

Keywords

-

Funding

  1. Diamond Light Source (Oxford) [MX14739-6, MX14739-11, 99170088]
  2. ARAID
  3. MEC [CTQ2013-44367-C2-2-P, BFU2016-75633-P, RTI2018-099592-B-C21]
  4. National Institutes of Health [GM113534, GM113534-01S]
  5. Danish National Research Foundation [DNRF107]
  6. FCT-Portugal [UID/Multi/04378/2013, IF/00780/2015, PTDC/BIA-MIB/31028/2017, UID/Multi/04378/2019]
  7. Gobierno de Aragon [E34_R17, E35_17R, LMP58_18]
  8. FEDER [2014-2020]
  9. Universidad de La Rioja
  10. PTNMR [ROTEIRO/0031/2013, PINFRA/22161/2016]
  11. Labex EpiGenMed, an 'Investissements d'avenir' program [ANR-10-LABX-12-01]
  12. FP7 (2007-2013) under BioStruct-X [283570, BIOSTRUCTX_5186]
  13. Fundação para a Ciência e a Tecnologia [PTDC/BIA-MIB/31028/2017] Funding Source: FCT

Ask authors/readers for more resources

Polypeptide GalNAc-transferase T3 (GalNAc-T3) regulates fibroblast growth factor 23 (FGF23) by O-glycosylating Thr178 in a furin proprotein processing motif (RHTR)-R-178 down arrow S. FGF23 regulates phosphate homeostasis and deficiency in GALNT3 or FGF23 results in hyperphosphatemia and familial tumoral calcinosis. We explored the molecular mechanism for GalNAc-T3 glycosylation of FGF23 using engineered cell models and biophysical studies including kinetics, molecular dynamics and X-ray crystallography of GalNAc-T3 complexed to glycopeptide substrates. GalNAc-T3 uses a lectin domain mediated mechanism to glycosylate Thr178 requiring previous glycosylation at Thr171. Notably, Thr178 is a poor substrate site with limiting glycosylation due to substrate clashes leading to destabilization of the catalytic domain flexible loop. We suggest GalNAc-T3 specificity for FGF23 and its ability to control circulating levels of intact FGF23 is achieved by FGF23 being a poor substrate. GalNAc-T3's structure further reveals the molecular bases for reported disease-causing mutations. Our findings provide an insight into how GalNAc-T isoenzymes achieve isoenzyme-specific nonredundant functions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available